Remove tag childrens-vaccines
article thumbnail

The Covid cash cow – a look at the Covid vaccine sales figures

pharmaphorum

The race to find and bring vaccines to market to fight Covid was impressive. It’s been almost a year since the first Covid vaccine was authorised for use. Meanwhile, China and Russia have rolled out state-owned vaccines. Pfizer/BioNTech’s vaccine dominates the market. billion in vaccine sales this year.

Sales 137
article thumbnail

Company Spotlight: Cue Biopharma Innovates in the Immunotherapy Space with its Immuno-STAT Platform

XTalks

protein-based biologics) and vaccine treatments. Treatment vaccines : these boost the immune system responses to target cells. In 2017, the US FDA approved a CAR-T cell treatment for young adults and children with B-cell ALL. chimeric receptor antigen [CAR] T cell) immune modulators (i.e. Immune system modulators (i.e.

Protein 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

A history of Johnson & Johnson

pharmaphorum

One McNeil product was the first prescription aspirin-free pain reliever, Tylenol (acetaminophen) elixir for children. J&J’s size meant that it had the resources to bring to bear against COVID-19 as the pandemic ravaged the world in 2020 and 2021, and the company soon began work on its own vaccine in partnership with the US government.

Sales 126
article thumbnail

Roche’s quantitative COVID-19 antibody test; Janssen buys a gene therapy asset; Zimmer Acquires A&E Medical; Glaucoma research study: Merck chooses TriNKET cancer immunotherapy program; Ovid fails Angelman phase 3 study

Delveinsight

The company anticipates the test can aid in tracking the success of vaccines and recognize people who have recovered from infection and could serve as convalescent plasma donors or help in the development of new therapies. In the 97-subject clinical trial, children who got OV101 orally once a day for three months improved by 0.7

article thumbnail

PFIZER REPORTS STRONG FIRST-QUARTER 2021 RESULTS

The Pharma Data

to $3.65, Primarily Reflecting Updates to Anticipated Contributions from BNT162b2 Partially Offset by Additional R&D Expenses for Vaccines to Protect Against COVID-19 as Well as Other mRNA-Based Development Programs and COVID-19 Antivirals. Raises Full-Year 2021 Guidance (3) for Revenues to a Range of $70.5 Adjusted Income (2).

article thumbnail

Merck KGaA raises full-year forecast; Perlmutter’s new gig tackles ‘undruggable targets’

The Pharma Data

. White House will make unordered vaccine supply available to other states ( WaPo ). White House set to send vaccines abroad ( Politico ). cases, vaccinations continue to drop as White House sets new inoculation goal ( CNBC ). inoculations ( CNBC ). CDC projects a surge in U.S. .